FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to a composition for preventing or treating cancer containing egg albumen combined with copper vitriol in an effective amount as an agent, as well as to a method for preventing or treating by administering said composition. The invention also refers to a functional health-improving foodstuff for preventing cancer or improving the cancer-associated condition, containing egg albumen and copper vitriol. What is also declared is a method for preparing the composition of egg albumen and copper vitriol wherein the method involves heating and dehydration of copper vitriol until the entire volume of copper vitriol becomes grey, cooling of dehydrated copper vitriol, powdering and mixing with egg albumen.
EFFECT: invention provides preparing the composition with evident anti-cancer activity which induces cancer cell apoptosis and inhibits their growth.
14 cl, 11 tbl, 14 dwg, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| RECOMBINANT ALBUMEN WITH ANTI-CANCER EFFECT, GENE CODING IT, AND APPLICATION THEREOF | 2003 |
|
RU2333221C2 |
| PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT COMPRISING INTERFERON-ALPHA CONJUGATE | 2012 |
|
RU2622077C2 |
| ANTIBODY BOUND WITH CARBONIC ANHYDRASE, AND USE THEREOF | 2017 |
|
RU2727682C1 |
| CANCER-MODIFYING ANTIBODIES | 2008 |
|
RU2468036C2 |
| ISOXAZOLE DERIVATIVE FOR TREATING CANCER | 2008 |
|
RU2491938C2 |
| FUSED DLK1-Fc PROTEIN AND USING IT FOR METASTASES INHIBITION, POLYNUCLEOTIDE CODING PROTEIN, VECTOR, HOST CELL, METHOD FOR PRODUCING FUSED PROTEIN, COMPOSITION AND METHOD FOR METASTASES INHIBITION | 2010 |
|
RU2531756C2 |
| COMBINATION INCLUDING AT LEAST ONE SPLICEOSOME MODULATOR AND AT LEAST ONE INHIBITOR SELECTED FROM BCL2 INHIBITORS, BCL2/BCLXL INHIBITORS, AND BCLXL INHIBITORS, AS WELL AS APPLICATION METHODS | 2018 |
|
RU2783239C2 |
| INTENSIFICATION OF ACTION OF ANTICANCER AGENTS | 2006 |
|
RU2422143C2 |
| COMBINATION OF PROTEIN KINASE INHIBITOR AND ADDITIONAL CHEMOTHERAPEUTIC AGENT | 2017 |
|
RU2785997C1 |
| ONCOGENIC RAS-SPECIFIC CYTOTOXIC COMPOUND AND METHODS FOR USING IT | 2006 |
|
RU2448703C2 |
